MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA ENHANCES GROWTH FACTOR-STIMULATED PHOSPHATIDYLCHOLINE METABOLISM AND INCREASES CAMP LEVELS IN THE HUMAN GROWTH FACTOR-DEPENDENT CELL-LINE M07E, EVENTS ASSOCIATED WITH GROWTH SUPPRESSION
C. Mantel et al., MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA ENHANCES GROWTH FACTOR-STIMULATED PHOSPHATIDYLCHOLINE METABOLISM AND INCREASES CAMP LEVELS IN THE HUMAN GROWTH FACTOR-DEPENDENT CELL-LINE M07E, EVENTS ASSOCIATED WITH GROWTH SUPPRESSION, The Journal of immunology, 154(5), 1995, pp. 2342-2350
The immunoregulatory C-C chemokine, macrophage inflammatory protein-1
alpha (MIP-1 alpha) has suppressive activity on proliferation of stem
cells and early subsets of myeloid progenitor cells. A receptor for C-
C chemokines that binds MIP-1 alpha has been characterized, cloned, an
d shown to be related structurally to neuropeptide receptors that coup
le through G-proteins to phospholipase-C and adenyl cyclase. Yet, very
little information on the intracellular mechanisms of action of MIP-1
alpha is available. We show here that the human factor-dependent cell
line M07e is responsive to the cell cycle-suppressive effects of MIP-
1 alpha, has specific membrane-binding sites for MIP-1 alpha, and that
treatment of these cells with this chemokine increases the phosphatid
ylcholine (PC) and phosphocholine turnover rates in cells that are syn
ergistically stimulated by the combination of granulocyte-macrophage c
olony-stimulating factor and steel factor but not by these factors act
ing singly. Additionally, MIP-1 alpha treatment induces a dose- and ti
me-dependent increase in intracellular cAMP levels in M07e cells. Both
exogenous PC and dibutyryl cAMP were found to suppress the proliferat
ion of M07e colony-forming cells to a level similar to that of MIP-1 a
lpha, further implicating cAMP and PC metabolism in MIP-1 alpha-induce
d M07e suppression. RANTES, a related chemokine, with weak or incomple
te binding to the cloned MIP-1 alpha receptor, did not suppress M07e c
olony-forming cells, nor did it increase intracellular cAMP levels, bu
t it did enhance growth factor-induced PC turnover, further supporting
the involvement of cAMP in MIP-1 alpha suppression while demonstratin
g that increased PC turnover alone is not sufficient for suppression.
These findings support the idea that the human MIP-1 alpha receptor is
coupled to phospholipid and cAMP metabolism in a manner similar to ot
her 7-transmembrane, C-protein-linked receptors and suggest that a pho
sphatidylcholine hydrolytic cycle and an associated increase in cAMP a
re part of the mechanisms of action of MIP-1 alpha.